wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41849636-447F9CBA-D971-4000-9640-733162287C67
Q41849636-447F9CBA-D971-4000-9640-733162287C67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41849636-447F9CBA-D971-4000-9640-733162287C67
Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies.
P2860
Q41849636-447F9CBA-D971-4000-9640-733162287C67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41849636-447F9CBA-D971-4000-9640-733162287C67
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e575ab7a512cf843559e2008f5deb7402367f50
P2860
Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial.